Nitric Oxide-Releasing Selective Estrogen Receptor Modulators: A Bifunctional Approach to Improve the Therapeutic Index
- 17 May 2019
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 62 (14) , 6525-6539
Abstract
When using selective estrogen receptor modulators (SERMs) in cancer therapy adverse effects such as endothelial dysfunction have to be considered. Estrogens and, consequently, SERMs regulate the synthesis of vasoactive nitric oxide (●NO). We hypothesized that a bifunctional approach combining the antagonistic action of SERMs with a targeted NO-release could diminish vascular side effects. We synthesized a series of NO-releasing SERMs (NO-SERMs) and the corresponding SERMs (after NO-release) derived from a triaryl olefin lead. Compounds showed antagonistic activity for ERβ (IC50(ERβ)=0.2–2.7µM), but no interaction with ERα. Growth of ERβ-positive breast cancer and melanoma cells was significantly decreased by treatment with SERM 5d. This anti-proliferative effect was diminished by the additional release of ●NO by the corresponding NO-SERM 4d. Moreover, targeted release of ●NO by 4d counteracted the anti-proliferative effect of 5d in normal vascular tissue cells. Summarizing, the therapeutic index of SERMs might be improved by this bifunctional approach.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (CRC/TRR 205/1)
- Technische Universit?t Dresden
- European Social Fund Plus
This publication has 46 references indexed in Scilit:
- Fluorinated COX-2 Inhibitors as Agents in PET Imaging of Inflammation and CancerCancer Prevention Research, 2011
- Triaryl (Z)-olefins suitable for radiolabeling with carbon-11 or fluorine-18 radionuclides for positron emission tomography imaging of cyclooxygenase-2 expression in pathological diseaseBioorganic & Medicinal Chemistry Letters, 2010
- Hypoxic tumor cell radiosensitization through nitric oxideNitric Oxide, 2008
- A Comparison of Letrozole and Tamoxifen in Postmenopausal Women with Early Breast CancerNew England Journal of Medicine, 2005
- Estrogen up-regulates cyclooxygenase-2 via estrogen receptor in human uterine microvascular endothelial cellsFertility and Sterility, 2004
- Antiestrogens and Selective Estrogen Receptor Modulators as Multifunctional Medicines. 2. Clinical Considerations and New AgentsJournal of Medicinal Chemistry, 2003
- Cofactor Dynamics and Sufficiency in Estrogen Receptor–Regulated TranscriptionCell, 2000
- Agonistic Effect of Tamoxifen Is Dependent on Cell Type, ERE-Promoter Context, and Estrogen Receptor Subtype: Functional Difference between Estrogen Receptors α and βBiochemical and Biophysical Research Communications, 1997
- Vascular estrogen receptors and endothelium-derived nitric oxide production in the mouse aorta. Gender difference and effect of estrogen receptor gene disruption.Journal of Clinical Investigation, 1997
- Estrogen Increases Endothelial Nitric Oxide by a Receptor Mediated SystemBiochemical and Biophysical Research Communications, 1995